James T. Parsons's Net Worth
$84.8 Thousand
Who is James T. Parsons?
James T. Parsons does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DiaMedica Therapeutics Inc., and Trillium Therapeutics Inc..
SEC CIK
James T. Parsons's CIK is 0001759855
Past Insider Trading and Trends
2021 was James T. Parsons's most active year for acquiring shares with 3 total transactions. James T. Parsons's most active month to acquire stocks was the month of May. 2021 was James T. Parsons's most active year for disposing of shares, totalling 10 transactions. James T. Parsons's most active month to dispose stocks was the month of October. 2021 saw James T. Parsons paying a total of $125,357.52 for 25,643 shares, this is the most they've acquired in one year. In 2021 James T. Parsons cashed out on 478,395 shares for a total of $134,270.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DiaMedica Therapeutics Inc. (DMAC) Snapshot price: $4.04
InvestorJames T. Parsons owns 59,937 units of Voting Common Shares, no par value per share which is worth $242,145.48. From 2018 to 2024 James T. Parsons acquired a total of 56,298 shares in DiaMedica Therapeutics Inc. at a cost of $229,975.27.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +55.64% | 21.43K |
$2.80 | $59,998.40 | 59.94K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +77.17% | 16.77K |
$3.58 | $60,047.34 | 38.51K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +54.53% | 7.75K |
$8.23 | $63,741.35 | 21.95K |
Jan 1
| |||
Form 4
| +132.82% | 8.1K |
$4.59 | $37,188.18 | 14.2K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +58.44% | 2.25K |
$4.00 | $9,000.00 | 6.1K |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Chief Financial OfficerJames T. Parsons used to own units in Common Shares but no longer holds any shares there. In the year 2021 James T. Parsons filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
$11.52 | -$72,654.82 |
0
|
Scheduled
|
Jan 8
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||